72955-77-2

Basic information

• Product Name: 1-(3-CHLOROPHENYL)-4-(2-PROPYNYL)PIPERAZINE
• Synonyms: 1-(3-CHLOROPHENYL)-4-(2-PROPYNYL)PIPERAZINE
• CAS NO: 72955-77-2
• Molecular Formula: C13H15ClN2
• Molecular Weight: 234.72
• Mol File: 72955-77-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(3-CHLOROPHENYL)-4-(2-PROPYNYL)PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-CHLOROPHENYL)-4-(2-PROPYNYL)PIPERAZINE(72955-77-2)
• EPA Substance Registry System: 1-(3-CHLOROPHENYL)-4-(2-PROPYNYL)PIPERAZINE(72955-77-2)

Safety Data

• Hazardous Substances Data: 72955-77-2(Hazardous Substances Data)

Upstream product

• 106-96-7 propargyl bromide 
• 6640-24-0 N-(m-chlorophenyl)piperazine 
• 51639-49-7 1-(3-chlorophenyl)piperazine hydrochloride 

Relevant articles and documents

A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking

Novel series of pleuromutilin analogs containing substituted 1,2,3-triazole moieties were designed, synthesised and assessed for their in vitro antibacterial activity against Methicillin-resistant Staphylococcus aureus (MRSA). Initially, the in vitro antibacterial activities of these derivatives against 4 strains of S. aureus (MRSA ATCC 43300, ATCC 29213, AD3, and 144) were tested by the broth dilution method. Most of the synthesised pleuromutilin analogs displayed potent activities. Among them, compounds 50, 62, and 64 (MIC = 0.5～1 μg/mL) showed the most effective antibacterial activity and their anti-MRSA activity were further studied by the time-killing kinetics approach. Binding mode investigations by surface plasmon resonance (SPR) with 50S ribosome revealed that the selected compounds all showed obvious affinity for 50S ribosome (KD = 2.32 × 10?8～5.10 × 10?5 M). Subsequently, the binding of compounds 50 and 64 to the 50S ribosome was further investigated by molecular modelling. Compound 50 had a superior docking mode with 50S ribosome, and the binding free energy of compound 50 was calculated to be ?12.0 kcal/mol.

NEW INHIBITORS OF CYCLOPHILINS AND USES THEREOF

The present invention relates to a compound of formula (I): Formula (I), wherein: - n is 0, 1 or 2; - A is in particular CH or N; - X is in particular CO, SO2, CS, and R1 is in particular H, - R2 is a group of formula NR3R4 or OR5, R3 and R4 being in particular H, and R5 an alkyl group, - R6 is in particular H or an alkyl group, and - R7 is in particular an aryl group, for its use in the prevention and/or the treatment of viral pathologies or infections.